| Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621) |
|---|
| 10/29/2009 | WO2009130534A1 Process for synthesizing atazanavir |
| 10/29/2009 | WO2009129938A1 Substituted phenoxybenzamides |
| 10/29/2009 | WO2009050365A3 Method for preparing (poly)aminoalkylaminoacetamide derivatives of epipodophyllotoxin, which can be used in therapeutics as an anticancer agent |
| 10/29/2009 | CA2720818A1 Substituted phenoxybenzamides |
| 10/28/2009 | EP1692098B1 Alpha-ketoamide derivative, and production method and use thereof |
| 10/28/2009 | CN101568260A Enantiomer-enriched alpha-,omega amino alcohol derivatives, their production and use as insect- and mite-repelling agents |
| 10/28/2009 | CN101565390A Method for preparing Alpha-methyl-Alpha, Alpha-disubstituted-Alpha-aminophenol and derivatives thereof |
| 10/28/2009 | CN101565389A Method for catalyzing and synthesizing hexamethylene-1,6-diamino methyl formate by using oxide |
| 10/28/2009 | CN100554249C Insecticide for agricultural or horticultural use and method of use thereof |
| 10/28/2009 | CN100554244C New mao-b inhibitors |
| 10/27/2009 | US7608590 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV) |
| 10/22/2009 | WO2009129532A1 Compounds for lysosomal modulation and methods of use |
| 10/22/2009 | WO2009129387A2 Cationic lipids and uses thereof |
| 10/22/2009 | WO2009129181A1 Propanediol-dicarbamate derivatives |
| 10/22/2009 | WO2009094577A3 Mesophasic forms of calcium-salts of (3s)-aminomethyl-b-methyl-hexanoic acids and methods of use |
| 10/22/2009 | US20090264487 Hemiasterlin analogs |
| 10/22/2009 | US20090263744 Ethylenically unsaturated compound, light sensitive composition, light sensitive planographic printing plate material and printing process employing the same |
| 10/21/2009 | EP2109600A2 Amorphous and crystalline forms of rivastigmine hydrogentartrate |
| 10/20/2009 | CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection |
| 10/20/2009 | CA2214793C Novel intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds |
| 10/15/2009 | US20090258884 Substituted amides |
| 10/14/2009 | EP1877367B1 Acetylene derivatives |
| 10/14/2009 | EP1720829B1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors |
| 10/14/2009 | CN100548955C New photoinitiators |
| 10/13/2009 | CA2370830C Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors |
| 10/08/2009 | WO2009094569A3 Method for the enzymatic kinetic resolution of acyloxyalkyl thiocarbonates used for the synthesis of acyloxyalkyl carbamates |
| 10/08/2009 | US20090253703 Organic compounds |
| 10/08/2009 | US20090253701 such as (2S,4S,5S,7S)-5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (2-phenoxy-ethyl)-amide, having renin-inhibiting properties, used for the treatment of hypertension, cardiovascular, vision, neurodegenerative, kidney and liver disorders |
| 10/07/2009 | CN101553463A New pharmaceutical intermediates in the synthesis of ace- inhibitors and the use thereof |
| 10/07/2009 | CN101550093A Method for preparing dyadic vinyl ethers monomer |
| 10/07/2009 | CN101548682A New method for synthesizing propamocarb hydrochloride of 722g/l |
| 10/07/2009 | CN100546977C New compounds for the inhibition of rotamases and use thereof |
| 10/01/2009 | WO2009119858A1 Benzene compound, and use thereof for medical purposes |
| 10/01/2009 | WO2009094563A3 Crystalline form of calcium-salts of (3s)-aminomethyl-b-methyl-hexanoic acids and methods of use |
| 10/01/2009 | US20090247784 Process and intermediates for the preparation of (1r,2s,5s)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof |
| 10/01/2009 | US20090242822 Perfluoroalkyl substituted phenol derivatives as surface modifiers |
| 09/29/2009 | US7595419 Process and intermediates for the preparation of 3-(amino)-3-cyclobutylmethyl-2-hydroxy-propionamide or salts thereof |
| 09/29/2009 | US7595399 Tyrosine derivatives |
| 09/29/2009 | US7595309 For therapy of bacterial infections and neoplasms, |
| 09/29/2009 | CA2391085C Bis-basic compounds as tryptase inhibitors, processes for preparing them and their use as phamaceutical compositions |
| 09/29/2009 | CA2176796C Substituted benzyloxycarbonylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 09/24/2009 | WO2009117095A1 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 09/24/2009 | WO2009115539A1 Metal carbamates composed of tolylenediamines |
| 09/24/2009 | WO2009115538A1 Method for producing urethanes composed of mono and di-functional aromatic amines |
| 09/24/2009 | WO2009115537A1 Metal carbamates formed from diaminophenylmethane |
| 09/24/2009 | WO2009053443A3 Indane compounds |
| 09/24/2009 | US20090239950 Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof |
| 09/24/2009 | US20090239832 Drugs for chronic pain |
| 09/24/2009 | CA2728756A1 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 09/23/2009 | EP2103601A1 Process for production of phenylalanine derivatives having quinazolinedione skeletons and intermediates for the production |
| 09/23/2009 | EP2102147A1 CHIRAL CYCLIC ß-AMINO ACIDS AND THEIR DERIVATES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THE USE OF SUCH COMPOUNDS |
| 09/23/2009 | CN101538226A Method for synthesizing optically active alpha-hydroxyl-beta-phenmethyl-beta-amino acid derivative |
| 09/22/2009 | US7592478 Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof |
| 09/22/2009 | US7592463 Enantioselective transformation of α,β-unsaturated ketones using chiral organic catalysts |
| 09/17/2009 | WO2009113608A1 Process for producing urethane (meth)acrylate |
| 09/17/2009 | US20090234138 Acyloxyalkyl carbamate prodrugs, methods |
| 09/17/2009 | US20090234002 Abuse-resistant amphetamine prodrugs |
| 09/17/2009 | US20090234001 Vitamin d receptor modulators |
| 09/16/2009 | EP2100876A2 New compounds for the inhibition of rotamases and use thereof |
| 09/16/2009 | CN100540571C Water- and oil-repellent fluoroacrylates |
| 09/16/2009 | CN100540526C Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/15/2009 | US7588880 Phenylglyoxylic acid type of low volatility, excellent initiator properties, dark-storage stability of formulations; used in thermally and photochemically curable component mixtures; binds in coating to prevent migration; addition-condensation polymers; photoresists; electronics; inks; adhesives; cables |
| 09/15/2009 | CA2342985C Hydroxamate-containing cysteine and serine protease inhibitors |
| 09/11/2009 | WO2009110859A1 Modulation of enzymatic structure, activity, and/or expression level |
| 09/11/2009 | WO2009109973A2 Compounds and methods of treating obesity |
| 09/11/2009 | WO2009109504A1 Enol carbamate derivatives as modulators of fatty acid amide hydrolase |
| 09/11/2009 | WO2009087682A3 Stabilized injectable formulation of pregabalin |
| 09/11/2009 | WO2008157740A3 Faah inhibitors |
| 09/11/2009 | CA2717511A1 Modulation of enzymatic structure, activity, and/or expression level |
| 09/09/2009 | CN100537538C Nove intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
| 09/09/2009 | CN100537534C Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 09/09/2009 | CN100537527C Aryl and biaryl compounds having MCH modulatory activity |
| 09/08/2009 | US7585996 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 09/08/2009 | US7585901 1,1-Disubstituted 2-vinylcyclopropanes; free radical polymerizable monomers; dental materials, in particular as dental adhesives, fixing cements or filling composites; low polymerization shrinkage, good mechanical properties |
| 09/08/2009 | US7585846 N-Acetyl L-Cysteine and L-Cysteine Choline Esters, and (R)-[2-(2,2-Dimethyl-thiazolidine-4-carbonyloxy)-ethyl]trimethyl-ammonium chloride, for example; compounds may be used to inhibit oxidative stress-induced cell injury or death both in vivo and ex vivo |
| 09/08/2009 | CA2401160C Biologically active analogs of discodermolide |
| 09/03/2009 | WO2009108484A1 Synthesis of a peg-6 moiety from commercial low-cost chemicals |
| 09/03/2009 | WO2009106237A2 Catalyst for the synthesis of alkyl carbamates, the method for preparing the same and the use thereof |
| 09/03/2009 | US20090221442 Substrates and screening methods for transport proteins |
| 09/02/2009 | CN101519367A Propoxur artificial antigen and method for synthesizing same |
| 09/02/2009 | CN101518729A Catalyst used for synthesizing alkyl carbamate and preparing method and application thereof |
| 09/01/2009 | US7582782 Organic compounds |
| 09/01/2009 | US7582668 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 09/01/2009 | CA2367368C Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |
| 08/27/2009 | WO2009071957A3 Novel peptides and amino acid derivatives, pharmaceutical compositions containing same and the use of these compounds |
| 08/27/2009 | US20090216037 Synthesis of Acyloxyalkyl Carbamate Prodrugs and Intermediates Thereof |
| 08/26/2009 | EP2091928A2 3-(2-acylamino-1-hydroxyethyl)- morpholine derivatives and their use as bace inhibitors |
| 08/26/2009 | EP1819693B1 Antithrombotic diamides |
| 08/26/2009 | EP1477488B1 Novel optically active compounds, method for kinetic optical resolution of carboxylic acid derivatives and catalysts therefor |
| 08/26/2009 | CN100532421C Novel phase change solvents |
| 08/25/2009 | US7579323 Analogs of hemiasterlin wherein the indole moiety of hemiasterlin has been deleted or replaced demonstrate potent anti-mitotic and cytotoxic activity; may be useful in treatment of colon, breast, lung cancers |
| 08/19/2009 | CN101511764A Perfluoroalkyl substituted phenol derivatives as surface modifiers |
| 08/19/2009 | CN100528348C Catalyst for synthesizing diphenyl methane diamino formic ether |
| 08/18/2009 | CA2443820C Process for the preparation of alkyl-n-(3-dimethylamino)alkylcarbamates |
| 08/13/2009 | WO2009098327A1 Method for producing fluorinated carbamates and isocyanates with heterogeneous catalysts |
| 08/13/2009 | WO2008004798A8 Compounds that inhibit hif-1 activity, the method for preparation thereof and the pharmaceutical composition containing them as an effective component |
| 08/13/2009 | US20090203918 Method for producing enantiomeric form of 2,3-diaminopropionic acid derivatives |
| 08/13/2009 | US20090203652 Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases |
| 08/13/2009 | US20090202573 Polymeric conjugates containing positively-charged moieties |